MED (STOCKS)
Medifast, Inc.
$10.925000
+0.075000 (+0.69%)
Prev close: $10.850000
Company Information
- Exchange
- XNYS
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- CEO
- Daniel R. Chard
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $120.08M
- Employees
- 504
- P/E (TTM)
- 519.14
- P/B (TTM)
- 0.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
4
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.21 | $-0.39 | +0.1839 | +46.69% |
|
Jun 2025 (Q2)
|
$0.22 | $-0.22 | +0.4422 | +199.01% |
|
Mar 2025 (Q1)
|
$-0.11 | $-0.27 | +0.1627 | +59.66% |
|
Dec 2024 (Q4)
|
$0.10 | $-0.16 | +0.2616 | +161.88% |
Financial Statements
| Revenues | $429.70M |
| Benefits Costs and Expenses | $427.68M |
| Cost Of Revenue | $118.43M |
| Costs And Expenses | $427.68M |
| Gross Profit | $311.27M |
| Nonoperating Income/Loss | $7.72M |
| Operating Expenses | $316.97M |
| Selling, General, and Administrative Expenses | $316.97M |
| Operating Income/Loss | -$5.70M |
| Income/Loss From Continuing Operations After Tax | $248.00K |
| Income/Loss From Continuing Operations Before Tax | $1.62M |
| Income Tax Expense/Benefit | $1.77M |
| Income Tax Expense/Benefit, Deferred | -$8.17M |
| Net Income/Loss | $248.00K |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $248.00K |
| Net Income/Loss Available To Common Stockholders, Basic | $248.00K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.02 |
| Diluted Earnings Per Share | $0.02 |
| Basic Average Shares | 10,979,000 |
| Diluted Average Shares | 10,981,000 |
| Assets | $268.21M |
| Current Assets | $207.84M |
| Cash | $172.81M |
| Inventory | $23.21M |
| Other Current Assets | $11.82M |
| Noncurrent Assets | $60.37M |
| Fixed Assets | $32.85M |
| Other Non-current Assets | $27.53M |
| Liabilities | $53.50M |
| Current Liabilities | $46.71M |
| Noncurrent Liabilities | $6.79M |
| Equity | $214.71M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $214.71M |
| Liabilities And Equity | $268.21M |
| Net Cash Flow From Operating Activities | $7.19M |
| Net Cash Flow From Operating Activities, Continuing | $7.19M |
| Net Cash Flow From Investing Activities | -$22.41M |
| Net Cash Flow From Investing Activities, Continuing | -$22.41M |
| Net Cash Flow From Financing Activities | -$566.00K |
| Net Cash Flow From Financing Activities, Continuing | -$566.00K |
| Exchange Gains/Losses | $0.00 |
| Net Cash Flow | -$15.78M |
| Net Cash Flow, Continuing | -$15.78M |
| Comprehensive Income/Loss | $120.00K |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $179.00K |
| Other Comprehensive Income/Loss | -$1.59M |
| Other Comprehensive Income/Loss Attributable To Parent | -$129.00K |